\"Principal Scientist siRNA Design

Roche Holding AG; Basel; Vor Ort; CHF 150.000 - 190.000; Vollzeit

Zusammenfassung

Roche Holding AG, basé à Bâle, au sein de pRED et de l’organisation Therapeutic Modalities (TMo), recherche un Principal Scientist en RNAi pour concevoir et optimiser des siRNA et des candidats thérapeutiques across les cibles biologiques. Vous participerez à la stratégie de conception et travaillerez avec des équipes pluridisciplinaires pour accélérer l’atteinte des objectifs cliniques.

Ce poste exige un doctorat et une expérience significative en design RNAi, ainsi qu’une maîtrise des

Qualifikationen

• Ph.D. in Molecular Biology, Bioinformatics, Biochemistry, or a related field, with 5+ years of industry experience in siRNA/RNAi design.
• Deep understanding of the RNAi mechanism and profiling of siRNA therapeutics.
• Proven track record in applying chemical modification patterns of siRNA to enhance therapeutic profile.
• Familiarity with biology/data science interface; able to discuss parameters with AI engineers; hands-on scripting for sequence analysis.
• Team player with strong communication and ability to integrate feedback from diverse stakeholders.

Aufgaben

• Lead the drug design strategy of oligonucleotides with a strong focus on siRNAs for initial Proof of Concept and lead optimization for clinical development.
• Guide projects holistically to ensure early design decisions align with late-stage clinical and manufacturing requirements.
• Invent and apply advanced chemical modification patterns and sequence selection strategies to optimize pharmacological properties of siRNAs.
• Collaborate with AI Experts to develop and validate AI design solutions with biological ground truth data.
• Act as RNAi SME in collaboration with project teams and disease experts.

Kenntnisse

RNAi design

Molecular biology

Data interpretation

Team collaboration

Ausbildung

PhD in Molecular Biology or related

Tools

Command-line utilities

Scripting languages

Sequence analysis tools

Jobbeschreibung

Chez Roche, vous pouvez être vous-même et être apprécié pour les qualités uniques que vous apportez. Notre culture encourage l'expression personnelle, le dialogue ouvert et les connexions authentiques, où vous êtes valorisé, accepté et respecté pour ce que vous êtes, vous permettant de prospérer tant personnellement que professionnellement. Voici comment nous visons à prévenir, arrêter et guérir les maladies et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir. Rejoignez Roche, où chaque voix compte.

La position

In Roche’s Pharmaceutical Research and Early Development organization (pRED), we make transformative medicines for patients in order to tackle some of the world’s toughest unmet healthcare needs. At pRED, we are united by our mission to transform science into medicines. Together, we create a culture defined by curiosity, responsibility, and humility, where our talented people are empowered and inspired to bring forward extraordinary life-changing innovation at speed.

Therapeutic Modalities (TMo) organization, accountable for translating disease biology into high-quality drug candidates across small molecules, large molecules, oligonucleotides, and genomic medicines. By integrating deep modality expertise with cross-disciplinary collaboration, TMo drives innovation within and across platforms to enable differentiated, sustainable therapeutic impact.

As the siRNA Design Principal Scientist, you will play a key role in designing and optimizing therapeutic siRNA against various disease targets working from Target Assessment through Lead Optimization across different disease areas. You will integrate deep scientific expertise with high quality execution of discovery programs.

The Opportunity

• Therapeutic Design Strategy: Lead the drug design strategy of oligonucleotides with a strong focus on siRNAs, leveraging computational and empirical approaches, for both initial Proof of Concept on novel targets and full-scale lead optimization for clinical development.

• Guide projects holistically ensuring early design decisions align with late-stage clinical and manufacturing requirements.

• Utilize and invent new advanced chemical modification patterns and sequence selection strategies to optimize relevant pharmacological properties of siRNAs

• AI Collaboration: Work in close partnership with our AI Experts to develop, validate, and apply the suit of AI design solutions. You understand AI needs and will provide the "ground truth" biological data and domain expertise to sharpen our machine-learning approaches.

• Cross-Functional Alignment: Act as the RNAi subject matter expert in collaboration with project teams and disease experts.

Who You Are

• Ph.D. in Molecular Biology, Bioinformatics, Biochemistry, or a related field with 5+ years of industry experience specifically in siRNA/RNAi therapeutic design.

• Deep understanding of the RNAi mechanism and profiling of siRNA therapeutics.

• Proven track record in applying chemical modification patterns of siRNA to enhance therapeutic profile.

• Familiarity with the interface of biology and data science; comfortable discussing parameters and data features with AI engineers; hands-on experience with command-line utilities and scripting languages for biological sequence analysis and data management.

• The "Team Player" Mindset: Ability to communicate complex nucleic acid chemistry to non-experts and integrate feedback from diverse stakeholders.

• Strategic Thinking: Ability to balance aggressive development timelines with meticulous attention to detail.

• Excellent communication skills, capable of translating complex scientific concepts into clear, actionable insights for diverse audiences.

At Roche, we aim high to deliver life-changing healthcare solutions. If you’re ready to make a meaningful impact on patients and healthcare systems worldwide, this is the place for you.

Qui nous sommes

Un avenir plus sain nous pousse à innover. Ensemble, plus de 100 000 employés à travers le monde sont dédiés à faire progresser la science et à garantir à chacun l'accès aux soins de santé aujourd'hui et pour les générations à venir. Nos efforts aboutissent à plus de 26 millions de personnes traitées avec nos médicaments et plus de 30 milliards de tests réalisés avec nos produits de Diagnostique. Nous nous encourageons mutuellement à explorer de nouvelles possibilités, à favoriser la créativité et à conserver nos grandes ambitions, afin de fournir des solutions de santé qui changent des vies et ont un impact mondial.

Construisons ensemble un avenir plus sain.

Roche est un employeur offrant l'équité en matière d'emploi.